1. [Evaluation of the possible ototoxicity of josamycin by high frequency audiometry].
- Author
-
Doménech J, Cuchí MA, Fusté J, and Traserra Coderch J
- Subjects
- Adult, Audiometry, Pure-Tone, Auditory Threshold, Cochlea drug effects, Erythromycin adverse effects, Female, Humans, Male, Middle Aged, Erythromycin therapeutic use, Hearing drug effects, Josamycin therapeutic use, Otorhinolaryngologic Diseases drug therapy
- Abstract
Josamycin is an antibiotic macrolide similar to erythromycin, with some differences in its biologic behaviour. There have been no reports of ototoxic effects caused by this drug, but its similitudes with erythromycin have prompted us to undertake a study about its possible cochleo-toxicity. Most trials of this kind have been carried out using conventional audiometry (up to 8,000 Hz), thus not being able to detect threshold shifts above this frequency. Ototoxic lesions usually begin in the upper frequency limit. Twenty-eight patients without previous auditory impairment were studied with conventional (up to 8,000 Hz) and high-frequency audiometry (up to 20,000 Hz) before and after oral treatment with josamycin during eight days. No significant differences were found in auditory thresholds registered before and after treatment in any of the patients. These results suggest that josamycin is devoid of any cochleo-toxic effect in all the frequencies that a normal subject can hear.
- Published
- 1993